Yujin Kim

Dr. Yujin Kim

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HJHan Jung
Han Jung
YKYujin Kim
Yujin Kim
HKHyojung Kim
Hyojung Kim
MKMin-Kyeong Kim
Min-Kyeong Kim
HLHyejung Lee
Hyejung Lee
JPJaesub Park
Jaesub Park
Background/Objectives: Socially assistive robots effectively support elderly care when they incorporate personalization, person-centered principles, rich interactions, and careful role setting with psychosocial alignment. Hyodol, a socially assistive robot designed for elderly people, embodies a grandchild’s persona, emulating the grandparent–grandchild relationship. Based on the behavioral activation principles and a human-centered approach, this robot continuously supports users’ emotional well-being, health management, and daily routines. Methods: The current study evaluated Hyodol’s impact on depressive symptoms and other quality of life factors among older adults living in medically underserved areas. A total of 278 participants were assessed for depressive symptoms, loneliness, medication adherence, and user acceptance. Results: After six months of use, participants showed significant reductions in overall depressive symptoms, with a 45% decrease in the proportion of individuals at high risk of depression. Significant improvements were also observed in loneliness and medication adherence. Participants reported high levels of user acceptance and satisfaction, exceeding 70% of the total score. Participants who engaged more frequently in free chat with Hyodol showed greater improvements in depressive symptoms. Conclusions: These results highlight Hyodol’s potential as a promising tool for enhancing mental healthcare and overall well-being in this population. This at-home mental-healthcare framework can complement primary care and, if its effects are confirmed in controlled trials, could contribute to reducing healthcare burden and preventing the onset and escalation of depressive symptoms.

6 April 2026 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
HJHan Jung
Han Jung
SPSEHWAN PARK
SEHWAN PARK
KCKyungmi Chung
Kyungmi Chung
YKYujin Kim
Yujin Kim
DRDaeyoung Roh
Daeyoung Roh
JPJaesub Park
Jaesub Park
Importance: Transcranial direct current stimulation (tDCS) is known to be promising for depression, but heterogeneity across studies highlights the need for strategies to optimize treatment effectiveness. Identifying distinct response patterns based on ecological momentary assessment (EMA) may enhance therapeutic outcomes and support the development of personalized and precision psychiatry. Objective: To identify distinct EMA-derived response profiles to tDCS in patients with depression and examine how the identified subtypes differentially predict treatment responses and symptom return following treatment termination. Design: A secondary analysis of a double-blind, multicenter randomized clinical trial investigating the effects of tDCS on depression. Daily EMA data on mood and sleep duration during the intervention period were processed using time-series feature extraction and clustered via Gaussian Mixture Modeling. Participants: One hundred and ninety-seven participants (original study) and 147 participants (current study) diagnosed with mild-to-moderate depression. Interventions or Exposures: Six-week active tDCS vs 3-week active and 3-week sham tDCS. Main Outcomes and Measures: Beck Depression Inventory-II (BDI-II) and Montgomery–Åsberg Depression Rating Scale (MADRS) measured at baseline (V1), post-treatment (V3), and 6-week follow-up (V4). Results: Clustering analysis identified 3 response types: (1) stable improvement (gradual mood reduction, stable sleep duration, moderate treatment effect with no symptom return), (2) persistent high-symptom (consistently elevated depressive mood, sleep disturbance, low-to-moderate treatment effect without symptom return), and (3) volatile symptom (large day-to-day variability in mood and sleep, marked acute improvement but high symptom return). The linear mixed model identified significant interaction effects between clusters and treatment efficacy (V1, V3)/symptom return (V3, V4) intervals. Conclusions and Relevance: Clustering of daily EMA data identified 3 distinct tDCS response profiles associated with different clinical characteristics and relapse risks. These patterns may reflect underlying subtypes of depression and highlight the value of individualized treatment planning. Future studies can fully characterize the subtypes of response profiles and the unique response patterns of individuals that may facilitate data-driven decision-making and support precision psychiatry by enabling tailored tDCS protocols based on patient-specific response characteristics.